BAXTER HLTHCARE Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAXTER HLTHCARE, and when can generic versions of BAXTER HLTHCARE drugs launch?
BAXTER HLTHCARE has two hundred and eighteen approved drugs.
There are twenty-one US patents protecting BAXTER HLTHCARE drugs. There are two tentative approvals on BAXTER HLTHCARE drugs.
There are thirty-seven patent family members on BAXTER HLTHCARE drugs in thirteen countries and three hundred and two supplementary protection certificates in sixteen countries.
Summary for BAXTER HLTHCARE
International Patents: | 37 |
US Patents: | 21 |
Tradenames: | 331 |
Ingredients: | 129 |
NDAs: | 218 |
Drugs and US Patents for BAXTER HLTHCARE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 018581-001 | Jul 28, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Baxter Hlthcare | ETHRANE | enflurane | LIQUID;INHALATION | 017087-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Baxter Hlthcare Corp | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride | SOLUTION;INTRAVENOUS | 216078-001 | Dec 15, 2022 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Baxter Hlthcare | HEPARIN SODIUM 5,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | heparin sodium | INJECTABLE;INJECTION | 018609-003 | Apr 28, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Baxter Hlthcare Corp | CEFAZOLIN IN DEXTROSE | cefazolin sodium | SOLUTION;INTRAVENOUS | 207131-001 | Aug 7, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Baxter Hlthcare | PENICILLIN G POTASSIUM IN PLASTIC CONTAINER | penicillin g potassium | INJECTABLE;INJECTION | 050638-001 | Jun 25, 1990 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BAXTER HLTHCARE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare | CYTOXAN (LYOPHILIZED) | cyclophosphamide | INJECTABLE;INJECTION | 012142-008 | Jan 4, 1984 | 4,537,883 | ⤷ Sign Up |
Baxter Hlthcare | NEXTERONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 022325-001 | Dec 24, 2008 | 6,869,939 | ⤷ Sign Up |
Baxter Hlthcare Corp | ZOSYN IN PLASTIC CONTAINER | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 050750-002 | Feb 24, 1998 | 8,133,883 | ⤷ Sign Up |
Baxter Hlthcare | IFEX/MESNEX KIT | ifosfamide; mesna | INJECTABLE;INJECTION | 019763-004 | Oct 10, 1992 | 5,696,172 | ⤷ Sign Up |
Baxter Hlthcare | EXTRANEAL | icodextrin | SOLUTION;INTRAPERITONEAL | 021321-001 | Dec 20, 2002 | 6,248,726 | ⤷ Sign Up |
Baxter Hlthcare | BREVIBLOC IN PLASTIC CONTAINER | esmolol hydrochloride | INJECTABLE;INJECTION | 019386-004 | Feb 16, 2001 | 6,528,540*PED | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for BAXTER HLTHCARE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Inhalation | 99.90% | ➤ Subscribe | 2008-09-11 |
➤ Subscribe | Injection | 10 mg/mL, 250 mL infusion bags and 20 mg/mL, 100 mL infusion bags | ➤ Subscribe | 2014-01-31 |
International Patents for BAXTER HLTHCARE Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 3363430 | ⤷ Sign Up |
Japan | 2015110671 | ⤷ Sign Up |
Eurasian Patent Organization | 201000828 | ⤷ Sign Up |
China | 101959508 | ⤷ Sign Up |
China | 115243675 | ⤷ Sign Up |
China | 114053423 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for BAXTER HLTHCARE Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2785706 | 122020000046 | Germany | ⤷ Sign Up | PRODUCT NAME: FOSNETUPITANT MIT PALONOSETRON; REGISTRATION NO/DATE: C(2020)1804(FINAL) 20200316 |
1189916 | 122011000010 | Germany | ⤷ Sign Up | PRODUCT NAME: REGADENOSON UND DIE SALZE DAVON; REGISTRATION NO/DATE: EU/1/10/643/001 20100906 |
2365988 | LUC00061 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: PATIROMER SORBITEX CALCIUM ET TOUS LES SELS ET DERIVES DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721 |
0206283 | 98C0041 | Belgium | ⤷ Sign Up | PRODUCT NAME: LEVOFLOXACINUM HEMIHYDRICUM; NAT. REGISTRATION NO/DATE: 354 IS 370 F3 19980624; FIRST REGISTRATION: GB 134020011 19970606 |
0820432 | SPC/GB05/044 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: HEXYL AMINOLEVULINATE, OPTIONALLY IN THE FORM OF A SALT, PREFERABLY HEXYL AMINOLEVULINATE HYDROCHLORIDE; REGISTERED: SE 19227 20040917; UK PL 18952/0003 20050714 |
2957286 | 6/2019 | Austria | ⤷ Sign Up | PRODUCT NAME: PATIROMER UND SEINE CALCIUM-SALZE; REGISTRATION NO/DATE: EU/1/17/1179 (MITTEILUNG) 20170721 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.